Bcl-2 in combination to myeloid antigen expression in adult acute lymphoblastic leukemia and prognostic outcome

Oncology Research

Volumn 17, Issue 10, 2009, Pages 447-454

  Amirghorfran, Zahra ^a,b   Daneshbod, Yahya ^a   Gholijani, Naser ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute lymphoblastic leukemia; Bcl 2; Myeloid antigens

Indexed keywords

CD19 ANTIGEN; CD33 ANTIGEN; CD7 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; MICROSOMAL AMINOPEPTIDASE; PROTEIN BCL 2; VINCRISTINE; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME; THROMBOCYTE COUNT; BONE MARROW; ENZYME IMMUNOASSAY; METABOLISM; MIDDLE AGED; PATHOLOGY; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD13; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BONE MARROW; CHILD; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349334533     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504009789735413     Document Type: Article

References (36)

1. Ferrara, F.; De Rosa, C.; Fasanaro, A.; Mele, G.; Finizio, O.; Schivone, O. A.; Rametta, V.; Del Vecchio, L. Myeloid expression in adult acute leukemia: Clinicohematological correlation and prognostic relevance. Hematol. Pathol. 4:93-98; 1990.
2. Cascavilla, N.; Musto, P.; D'Arena, G.; Ladogana, S.; Matera, R.; Carotenuto, M. Adult and childhood acute lymphoblastic leukemia: Clinico-biological differences based on CD34 antigen expression. Haematologia 82:31-37; 1997.
3. Boldt, D. H.; Kopecky, K. J.; Head, D.; Gehly, G.; Radich, J. P.; Appelbaum, E. R. Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experiences. Leukemia 8: 2118-2126; 1994.
4. Davey, F. R.; Mick, R.; Nelson, D. A.; MacCallum, J.; Sobol, R. E.; Royston, I.; Cuttner, J.; Ellison, R. P.; Bloomfield, C. D. Morphologic and cytochemical characterization of adult lymphoid leukemias which express myeloid antigen. Leukemia 2:420-426; 1988.
5. Smith, L. J.; Curtis, J. E.; Messner, H. A.; Senn, J. S.; Furthmayr, H.; McCulloch, E. A. Lineage infidelity in acute leukemia. Blood 61:1138-1145; 1983.
6. Greaves, M. F. Differentiation-linked leukemogenesis in lymphocytes. Science 234:697-704; 1986.
7. Greaves, M. F.; Chan, L. C.; Furley, A. J. W.; Watt, S. M.; Molgaard, H. V. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 67:1-11; 1986.
8. Wiersma, S. R.; Ortega, J.; Sobol, E.; Weinberg, K. I. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. N. Engl. J. Med. 324:400-408; 1991.
9. Weiner, M.; Borowitz, M.; Boyett, J.; Civin, K.; Metzger, R.; McKolnis, J.; Crist, W.; Dowell, B.; Pullen, J. Clinical pathologic aspects of myeloid antigen positivity in pediatric patients with acute lymphoblastic leukemia (ALL). Proc. Am. Soc. Clin. Oncol. 4:172; 1985.
10. Cacciola, E.; Guglielmo, P.; Cacciola, E.; Stagno, F.; Cacciola, R. R.; Impera, S. CD34 expression in adult acute lymphoblastic leukemia. Leuk. Lymphoma 1:31-36; 1995.
11. Pui, C. H.; Bchm, F. G.; Singh, B.; Rivera, G. K.; Schell, M. J.; Roberts, W. M.; Crist, W. M.; Mirro, Jr., J. Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood 75:198-202; 1990.
12. Boucheix, C.; David, B.; Sebban, C.; Racadot, E.; Bene, M. C.; Bernard, A.; Compos, L.; Jouault, H.; Sigaux, F.; Lepage, E.; Herve, P.; Fiere, D. Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: An analysis of a prospective trial inducing 562 tested patients (LALA86). Blood 84:1603-1612; 1994.
13. Jattela, M. Multiple cell death pathways are regulators of tumour initiation and progression. Oncogene 23:2746-2756; 2004
14. Kirkin, V.; Joos, S.; Zornig, M. The role of Bcl-2 family members in tumorigenesis. Biochim. Biophys. Acta. 1644: 229-249; 2004.
15. Pommier, Y.; Sordet, O.; Antony, S.; Harward, R. L.; Kohn, K. W. Apoptosis defects and chemotherapy resistance. Oncogene 23:2934-2949; 2004.
16. Linjawia, A.; Kontogiannea, M.; Halwani, F.; Edwardes, M.; Meterissian, S. Prognostic significance of p53, bel-2 and Bax expression in early breast cancer. J. Am. Coll. Surg. 198:83-90; 2004.
17. Amirghofran, Z.; Monabati, A.; Gholijani, N. Androgen receptor expression in relation to apoptosis and the expression of cell cycle related proteins in prostate cancer. Pathol. Oncol. Res. 10:37-41; 2004.
18. Narayan, S.; Chandra, J.;. Sharma, M.; Naithani, R.; Sharma, S. Expression of apoptosis regulators Bcl-2 and Bax in childhood acute lymphoblastic leukemia. Hematology 12: 39-43; 2007.
19. Del Principe, M. I.; Del Poeta, G.; Maurillo, L.; Buccisano, F.; Venditti, A.; Tamburini, A.; Bruno, A.; Cox, M. C.; Suppo, G.; Tendas, A.; Giannì, L.; Postorino, M.; Masi, M.; Del Principe, D.; Amadori, S. P-glycoprotein and Bcl-2 levels predict outcome in adult acute lymphoblastic leukaemia. Br. J. Haematol. 121:730-738; 2003.
20. Aref, S.; Salama, O.; Al-Tonbary, Y.; Mansour, A. Assessment of bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia. Hematology 9:113-121; 2004.
21. Hafez, M.; Al-Tonbary, Y.; El-Bayoumi, M. A.; Hatem, N.; Hawas, S.; Mansour, A.; Marzouk, I.; Hafez, M. M.; Yahia, S.; Farahat, N. Markers of apoptosis and proliferation related gene products as predictors of treatment outcome in childhood acute lymphoblastic leukemia. Hematology 12:209-218; 2007.
22. Kaplan, E. L.; Meier, P. Non-parametric estimation from incomplete observations. J. Am. Statist. Assoc. 53:457-481; 1958.
23. Freeman, S. D.; Kelm, S.; Barber, E. K.; Crocker, P. R. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood 85: 2005-2012; 1995.
24. Amirghofran, Z.; Shassedin, A.; Zakrinia, M.; Ramzi, M.; Nourani, H. Immunophenotypic analysis in Iranian patients with acute myelogenous leukemia: Correlation with leukemia subgroups. Iranian J. Med. Sci. 24:40-43; 1999.
25. Yeager, C. L.; Ashmun, R. A.; Williams, R. K.; Cardellichio, C. B.; Shapiro, L. H.; Look, A. T.; Holmes, K. V. Human aminopeptidase N is a receptor for human corona-virus 229E. Nature 357:420-402; 1992.
26. Abdelhaleem, M. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia. Exp. Mol. Pathol. 83:138-141; 2007.
27. Preti, H. A.; Huh, Y. O.; O'Brien, S. M.; Andreeff, M.; Pierce, S. T.; Keating, M.; Kantarjian, H. Myeloid markers in adult acute lymphoblastic leukemia. Cancer 76: 1564-1570; 1995.
28. Sobol, R. E.; Mick, R.; Royston, I.; Davey, F. R.; Ellison, R. R.; Newman, R.; Cuttner, J.; Griffin, J. D.; Collins, H.; Nelson, D. A.; Bloomfield, C. D. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N. Engl. J. Med. 316:1111-1117; 1986.
29. Urbano-Ispizua, A.; Matutes, E.; Villamor, N.; Ribera, J. M.; Feliu, E.; Montserrat, E.; Granena, A.; Vives-Corrons, J. L.; Rozman, C. Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukemia. Br. J. Haematol. 75:202-207; 1994.
30. Vitale, A.; Guarini, A.; Ariola, C.; Meloni, G.; Perbellini, O.; Pizzuti, M.; De Gregoris, C.; Mettivier, V.; Pastorini, A.; Pizzolo, G.; Vignetti, M.; Mandelli, F.; Foà, R. Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial. Haematologica 92:342-348; 2007.
31. Plensa, E.; Ribera, J. M.; Oriol, A.; Bethencourt, C.; Parody, R.; Hernández Ribas, J. M.; Moreno, M. J.; del Potro, E.; Tormo, M.; Rivas, C.; Besalduch, J.; Sanz, M. A.; Arias, J.; Fernández Calvo, J.; Moraleda, J. M.; Bueno, J.; Felin, E.; Ortega, J. J.; Grupo PETHEMA. Prevalence and prognostic significance of myeloid markers in adults with high-risk acute lymphoblastic leukemia. Med. Clin. (Barc.) 125: 241-246; 2005.
32. Hannun, Y. A. Apoptosis and the dilemma of cancer chemotherapy. Blood 89:1845-1853; 1997.
33. Maung, Z. T.; MacLean, F. R.; Reid, M. M.; Pearson, A. D.; Proctor, S. J.; Hamilton, P. J.; Hall, A. G. The relationship between bel-2 expression and response to chemotherapy in acute leukaemia. Br. J. Haematol. 88: 105-109; 1994.
34. Daneshbod, Y.; Amirghofran, Z.; Tabei, S. Z. Bcl-2 expression in acute myelogenous leukemia: The relation to myeloid antigen expression and response to therapy in Iranian patients. Neoplasma 52:109-114; 2005.
35. Salomons, G. S.; Smets, L. A.; Verwijs-Janssen, M.; Hart, A. A.; Haarman, E. G.; Kaspers, G. J.; Wering, E. V.; Der Does-Van Den Berg, A. V.; Kamps, W. A. Bcl-2 family members in childhood acute lymphoblastic leukemia: Relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome. Leukemia 13:1574-1580; 1999.
36. Campos, L.; Sabido, O.; Sebban, C.; Charrin, C.; Bertheas, M. F.; Fière, D.; Guyotat, D. Expression of BCL-2 proto-oncogene in adult acute lymphoblastic leukemia. Leukemia 10:434-438; 1996.